Premium Only Content

Aridis Pharmaceuticals: Revolutionizing Infectious Disease Treatment with AR-301
Aridis Pharmaceuticals (NASDAQ: ARDS) is advancing multiple clinical stage monoclonal antibodies (mAbs) targeting bacteria that cause life-threatening infections such as ventilator associated pneumonia (VAP) and hospital acquired pneumonia (HAP), in addition to preclinical stage antiviral mAbs. The use of mAbs as anti-infective treatments represents an innovative therapeutic approach that harnesses the human immune system to fight infections and is designed to overcome the deficiencies associated with the current standard of care which is broad spectrum antibiotics. Such deficiencies include, but are not limited to, increasing drug resistance, short duration of efficacy, disruption of the normal flora of the human microbiome and lack of differentiation among current treatments. The mAb portfolio is complemented by a non-antibiotic novel mechanism small molecule anti-infective candidate being developed to treat lung infections in cystic fibrosis patients. Visit AridisPharmaInfo.com to learn more.
-
35:05
Stephen Gardner
4 hours ago🔥Obama will be FORCED to Testify in Trump trial?
11.1K23 -
Tundra Tactical
1 hour agoTundra Tactical Political Memes Review!
4.46K -
LIVE
GloryJean
2 hours agoDuos w/ Spartakus 🔥 LOCK IN for Games w/ PASSION
17 watching -
LIVE
Sgt Wilky Plays
2 hours agoSniper in the bushes
33 watching -
LIVE
Kimberly Guilfoyle
5 hours ago"Burns Bags" at FBI, What's Next? Interview with Former Agent John Nantz | Ep242
552 watching -
LIVE
RamrodJenkins
2 hours agoI'm HYPED for BF6 so let's play some 2042!
21 watching -
LIVE
FusedAegisTV
8 hours agoInto The Belly Of Human Cognition | Persona 5 Royal PART 23
25 watching -
6:00
SKAP ATTACK
10 hours ago $0.34 earnedSkinny Luka is Terrifying
6.47K -
18:33
World2Briggs
6 hours ago $0.47 earnedWhy Did Mississippi Go From Rich To Poor?
7.42K8 -
11:21
Anthony Rogers
4 hours agoKILLSWITCH ENGAGE interview
7.61K1